Advertisement
Advertisement

PEN

PEN logo

Penumbra, Inc.

303.50
USD
-10.36
-3.42%
Feb 21, 16:00 UTC -5
Closed
exchange

After-Market

291.665

-11.83
-3.90%

Penumbra, Inc. Profile

About

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.

Info & Links

CEO

Adam Elsesser

Headquarters

One Penumbra Place
Alameda, CA 94502, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

www.penumbrainc.com

Auditor

Deloitte & Touche LLP

Share holders

32

Employees

4,200

Penumbra, Inc. Statistics

Valuation Measures

Market Capitalization2

11.19B

Enterprise Value

10.94B

Enterprise Value/EBITDA(ttm)

392.24

Price to Earnings Ratio(ttm)

105.62

Price to Sales(ttm)

9.77

Price to Book(mrq)

10.11

Price to Cash(ytd)

105.01

Profitability

Gross Margin(ttm)

63.18%

Operating Margin(ttm)

9.42%

Profit Margin(ttm)

1.08%

Return on Equity(ttm)

9.74%

Return on Invested Capital(ttm)

1.30%

Return on Assets(ttm)

7.35%

Income Statement

Revenue(ttm)

1.16B

Revenue Per Share(ttm)

30.32

Gross Profit(ttm)

731.27M

EBITDA(ttm)3

27.89M

Net Income Available to Common(ttm)

34.55M

Diluted EPS(ttm)

0.34

Share Statistics

Beta (5Y Monthly)

0.53

52-Week Change

15.54%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

38.38M

Dividend Yield

0.00%

Float4

36.59M

% Held by Insiders

5.00%

% Held by Institutions

88.88%

Balance Sheet

Total Cash(mrq)

291.02M

Total Cash Per Share(mrq)

7.58

Total Debt(mrq)

24.66M

Total Debt/Equity(mrq)

2.09%

Current Ratio(mrq)

6.01%

Quick Ratio(mrq)

3.25%

Book Value Per Share(mrq)

29.90

Cash Flow

Operating Cash Flow Per Share(ytd)

4.29

Free Cash Flow(ytd)

147.30M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement